SCHEMBL19494934

SCHEMBL19494934

NC(=O)c1cc(Sc2ccc(F)cc2)sc1NC(=O)c1cccnn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.41
▸ TDP1 Q9NUW8 3/20 0.41
▸ IKBKB O14920 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ JAK2 O60674 2/20 0.41
▸ EIF2AK2 P19525 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ CFTR P13569 3/20 0.40
▸ P2RX7 Q99572 1/20 0.40
▸ AHR P35869 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ OPRK1 P41145 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19494512 0.80 IKBKB (0.41) KMT2ATDP1IKBKBMEN1JAK2
SCHEMBL16246522 0.79 CFTR (0.65) KMT2ATDP1IKBKBMEN1JAK2
SCHEMBL19494413 0.77 IKBKB (0.46) KMT2ATDP1IKBKBMEN1JAK2
SCHEMBL19494660 0.76 TYK2 (0.46) KMT2ATDP1IKBKBMEN1JAK2
SCHEMBL19494898 0.75 JAK2 (0.45) KMT2ATDP1IKBKBMEN1JAK2
SCHEMBL19494396 0.74 CFTR (0.43) KMT2ATDP1IKBKBMEN1JAK2
SCHEMBL19494442 0.73 MEN1 (0.42) KMT2ATDP1IKBKBMEN1JAK2
SCHEMBL19494900 0.73 NPC1 (0.47) KMT2ATDP1IKBKBMEN1JAK2
SCHEMBL19494938 0.72 MEN1 (0.41) KMT2ATDP1IKBKBMEN1JAK2
SCHEMBL19494384 0.69 CFTR (0.54) KMT2ATDP1IKBKBMEN1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback